HAT-SIL-TG-1&AT
HAT-SIL-TG-1&AT is a hypoxia-activated prodrug that acts as a Janus kinase (JAK) inhibitor. It exerts antitumor effects by blocking the JAK-STAT pathway, suppressing HEL cell proliferation and reducing phospho-STAT3/5 levels under hypoxia, making it a tool for studying hypoxia-targeted oncology research.
Product Specifications
Field of Research
Cardiovascular Research, Epigenetics & Chromatin, Signal Transduction, Stem Cell & Developmental Biology
Molecular Formula
C60H69N17O11S
Molecular Weight
1236.36
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1269829-01 0.01 mg Plasmid + 0.2 mL Glycerol-Stock
DLC1 cDNA Clone
Sign In for Pricing
View Details MBS1269829-02 5x 0.01 mg Plasmid + 5x 0.2 mL Glycerol-Stock
DLC1 cDNA Clone
Sign In for Pricing
View Details 
TRV-0056169-01 20 µL
Polyclonal Antibody to Pulmonary Surfactant Associated Protein A1 (SFTPA1)
Sign In for Pricing
View Details TRV-0056169-02 100 µL
Polyclonal Antibody to Pulmonary Surfactant Associated Protein A1 (SFTPA1)
Sign In for Pricing
View Details TRV-0056169-03 200 µL
Polyclonal Antibody to Pulmonary Surfactant Associated Protein A1 (SFTPA1)
Sign In for Pricing
View Details